Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

EMA Panel Recommends Victrelis Approval

May 20, 2011 11:21 am | News | Comments

Drugmaker Merck & Co. said that a European drug agency has endorsed its hepatitis C treatment Victrelis, also known as boceprevir - a key step toward possible approval in the European Union.


FDA Approves New HIV Drug

May 20, 2011 11:19 am | News | Comments

The Food and Drug Administration said it approved a new HIV drug from Johnson & Johnson for patients who have not been treated with other medications for the virus.


Pearl Therapeutics Study Shows Lung Function Improvement

May 20, 2011 6:21 am | News | Comments

Pearl Therapeutics Inc. presented efficacy and safety results in the company's Phase 2b study of PT003 (GFF MDI) in patients with moderate-to-very severe COPD at the annual meeting of the American Thoracic Society (ATS).


Safety Committee Reports Findings on Gardasil

May 20, 2011 6:16 am | News | Comments

An independent safety review committee reported study findings on nearly 190,000 females who received at least one dose of Merck’s Gardasil, a quadrivalent human papillomavirus vaccine (qHPV) at two managed care associations between August 2006 and March 2008.


Eli Lilly Names Senior Medical Advisor

May 20, 2011 6:12 am | News | Comments

David M. Kendall, MD, currently chief scientific and medical officer of the American Diabetes Association, has been named distinguished medical fellow for Lilly.


Late-Stage Fluorination Company Secures Funding

May 20, 2011 6:08 am | News | Comments

SciFluor Life Sciences  has secured $5 million in first-round funding from Allied Minds for a technology that enables late-stage fluorination of pharmaceutical drug candidates and other commercial chemicals.


Study Questions Ezetimibe Benefits

May 20, 2011 6:03 am | News | Comments

While physicians routinely prescribe statin therapy combined with ezetimibe for some patients with high cholesterol., a study by University of Virginia Health System researchers adds to mounting evidence that ezetimibe may not stop significant artery wall thickening, or atherosclerosis, in some patients.


Packaging Process for Genes Discovered

May 20, 2011 5:56 am | News | Comments

Penn State University scientists have assembled entire chromosomes from their component parts in a test tube, an achievement that reveals the process a cell uses to package the basic building blocks of an organism's genome.


FDA Panel Backs Key Use of Abbott Cholesterol Drug

May 20, 2011 5:43 am | News | Comments

WASHINGTON (AP) - A Food and Drug Administration advisory panel recommended on May 19, 2011 that a blockbuster drug from Abbott Laboratories still be marketed for use with other widely used cholesterol-lowering drugs, despite a government study that questioned the benefit.


European Committee Endorses Benlysta For Approval

May 20, 2011 5:34 am | News | Comments

ROCKVILLE, Md. (AP) - Biotech drugmaker, Human Genome Sciences Inc., said on May 20, 2011 a European committee has endorsed its lupus treatment Benlysta, a key step toward possible approval in the European Union.


Two Genes Linked to Worst Esophageal Cancer

May 19, 2011 11:54 am | News | Comments

Researchers have pinpointed two genes that are amplified in the worst cases of esophageal cancer, providing data to support a new investigational treatment that targets those same genes.


Gene Therapy Success Depends on Commercialization

May 19, 2011 11:50 am | News | Comments

Many gene therapy strategies designed to deliver a normal copy of a gene to cells carrying a disease-causing genetic mutation rely on a modified virus to transfer the gene product into affected tissues.


ImageIQ Spins Out of CCI

May 19, 2011 11:45 am | News | Comments

ImageIQ, an imaging contract research organization specializing in advanced medical image acquisition, analysis, and visualization, announced the company’s spin-out of technology and expertise developed at Cleveland Clinic Innovations.


TTP Labtech Sponsoring First ELA Conference

May 19, 2011 11:41 am | News | Comments

TTP LabTech announce that they are founding sponsors of the inaugural European Lab Automation conference and exhibition, to be held at the Conference Center Hamburg, Hamburg, Germany, from the June 30 - July 1.


Targeted Genotyping Arrays

May 19, 2011 11:36 am | Product Releases | Comments

Affymetrix, Inc. launched the Axiom myDesign Targeted Genotyping Arrays for the targeted genotyping market, enabling researchers to study mutations in disease pathways and characterize gene-gene interactions.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.